United States: New York Attorney General Enters Settlement With Three mHealth App Developers

Last week, the New York Office of the Attorney General ("OAG") announced settlements with three mobile health application developers to resolve allegations that the companies made misleading claims and engaged in "irresponsible privacy practices." The three companies that entered into settlements are:

  • Cardiio, a U.S.-based company that sells Cardiio, an app that claims to measure heart rate;
  • Runtastic, an Austria-based company that sells Runtastic, an app that purports to measure heart rate and cardiovascular performance under stress (downloaded approximately 1 million times); and
  • Matis, an Israel-based company that sells My Baby's Beat, an app which Matis previously claimed could turn any smartphone into a fetal heart monitor, without FDA approval for such use.

With respect to Cardiio (settlement) and Runtastic (settlement), OAG alleged that both companies failed to test the accuracy of their apps under the conditions for which the apps were marketed (e.g., failed to test the product on subjects who had engaged in vigorous exercise, despite marketing the app for that purpose"). In addition, the OAG alleged that both companies' apps claimed to accurately measure heart rate after vigorous exercise while using only a smartphone camera and sensors. OAG also alleged that Cardiio's marketing practices included false endorsements. For example, Cardioo was charged with making claims that "misleadingly implied that the app was endorsed by MIT," when Cardiio's technology was based only on technology licensed from MIT and originally developed at the MIT Media Lab.

With respect to Matis (settlement), OAG alleged that the company deceived customers into using the My Baby's Beat instead of a fetal heart monitor or Doppler, even though the app was not FDA-approved for such use and the company had "never conducted ... a comparison to a fetal heart monitor, Doppler, or any other device that had been scientifically proven to amplify the sound of a fetal heartbeat."

In each settlement agreement, OAG cites various claims made by the companies on the App or Google Play Stores (including product reviews by consumers), company websites, and other promotional materials. The OAG asserted that the "net impression" conveyed to consumers about such apps by these claims were misleading and unsubstantiated. In addition, OAG alleged that each company failed to obtain FDA approval for their apps and noted in the settlements that FDA generally regulates cardiac monitors as Class II devices under 21 C.F.R. § 870.2300 and fetal cardiac monitors as Class II devices under 21 C.F.R. § 884.2600.

Under the settlements, Cardiio and Runtastic each paid $5,000 in civil penalties, and Matis paid $20,000. Further, each company is required to take the following corrective actions:

  1. Amend and correct the deceptive statements made about their apps to make them non-misleading;
  2. Provide additional information about the testing conducted on their apps (e.g. substantiation);
  3. Post clear and prominent disclaimers informing consumers that their apps are not medical devices, are not for medical use, and are not approved or cleared by the FDA; and
  4. Modify their privacy policies to better protect consumers

With respect to privacy, the companies must now require the affirmative consent to their privacy policies for these apps and disclose that they collect and share information that may be personally identifying. This includes users' GPS location, unique device identifier, and "de-identified" data that third parties may be able to use to re-identify specific users.

In addition, if the companies make any "material change" to their claims concerning the functionality of their apps, the companies must: (1) perform testing to substantiate any such claims; (2) conduct such testing using researchers qualified by training and experience to conduct such testing; and (3) secure and preserve all data, analyses, and documents regarding such testing, and make them available to the OAG upon request.

The OAG explained that the settlements follow a year-long investigation of mobile health applications, which include "more than 165,000 apps that provide general medical advice and education, allow consumers to track their fitness or symptoms based on self-reported data, and promote healthy behavior and wellness." Of these apps, the OAG appears to be focusing its enforcement on a "narrower subset of apps [that] claim to measure vital signs and other key health indicators using only a smartphone [camera and sensors, without any external device], which can be harmful to consumers if they provide inaccurate or misleading results."

Referred to as "Health Measurement Apps," the OAG expressed concern that such apps could "provide false reassurance that a consumer is healthy, which might cause [them] to forgo necessary medical treatment and thereby jeopardize [their] health." Conversely, Health Measurement Apps "can incorrectly indicate a medical issue, causing a consumer to unnecessarily seek medical treatment – sometimes from a hospital emergency room."

The OAG's risk-based approach appears to be consistent with FDA's risk-based approach for regulating general wellness products, which Congress expressly excluded from the definition of medical "device" in Section 3060 of the recently enacted 21st Century Cures Act ( read our Advisory here).

Ultimately, this settlement demonstrates that in addition to traditional regulators such as the FTC and FDA, which have taken a number of recent enforcement actions against mHealth app developers (as we've discussed here, here, and here), state consumer protection laws may also be implicated by such products. Accordingly, companies should continue to establish, implement, and execute robust quality or medical/clinical programs to support any research needed to substantiate claims made about mHealth products. And, more importantly, digital health companies should create strong promotional review committees that consistent of legal, medical, and regulatory professionals who can properly vet any advertising or promotional claims to mitigate potentially false, misleading, or deceptive claims that could trigger enforcement by regulatory agencies and prosecutors.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.